These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 11602611

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The tyrosyl free radical in ribonucleotide reductase.
    Gräslund A, Sahlin M, Sjöberg BM.
    Environ Health Perspect; 1985 Dec; 64():139-49. PubMed ID: 3007085
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of new iron chelators for clinical use.
    Porter JB.
    Acta Haematol; 1996 Dec; 95(1):13-25. PubMed ID: 8604583
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S, Link G, Grady RW, Hider RC, Peter HH, Hershko C.
    Blood; 1992 Jan 01; 79(1):248-53. PubMed ID: 1728313
    [Abstract] [Full Text] [Related]

  • 29. EPR study of the mixed-valent diiron sites in mouse and herpes simplex virus ribonucleotide reductases. Effect of the tyrosyl radical on structure and reactivity of the diferric center.
    Davydov RM, Davydov A, Ingemarson R, Thelander L, Ehrenberg A, Gräslund A.
    Biochemistry; 1997 Jul 29; 36(30):9093-100. PubMed ID: 9230041
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.
    Green DA, Antholine WE, Wong SJ, Richardson DR, Chitambar CR.
    Clin Cancer Res; 2001 Nov 29; 7(11):3574-9. PubMed ID: 11705879
    [Abstract] [Full Text] [Related]

  • 33. Selenite incubated with NADPH and mammalian thioredoxin reductase yields selenide, which inhibits lipoxygenase and changes the electron spin resonance spectrum of the active site iron.
    Björnstedt M, Odlander B, Kuprin S, Claesson HE, Holmgren A.
    Biochemistry; 1996 Jul 02; 35(26):8511-6. PubMed ID: 8679612
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded mice.
    Porter JB, Hoyes KP, Abeysinghe RD, Brooks PN, Huehns ER, Hider RC.
    Blood; 1991 Nov 15; 78(10):2727-34. PubMed ID: 1824264
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cellular adaptation to down-regulated iron transport into lymphoid leukaemic cells: effects on the expression of the gene for ribonucleotide reductase.
    Chitambar CR, Wereley JP, Heiman T, Antholine WE, O'brien WJ.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):681-5. PubMed ID: 10642528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.